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Recent investigations indicate that the liver is involved in the selective transport of 
serum IgA into the bile. In rats, ligation of the bile duct results in a rapid increase in 
the concentration of circulating IgA, which is reversed upon removal of the ligature 
(1,  2).  Radiolabeled  IgA  infused  intravenously  in  rats  and  mice  is  rapidly  and 
selectively cleared from the circulation and transported to the bile (2-4). This process 
appears to be selective for oligomeric IgA, to involve secretory component (SC) 1 as an 
IgA receptor on  the  hepatocytes, and  to result  in  the  appearance of secretory IgA 
(SIgA) in the bile (5, 6). 
The Kupffer cells of the liver are known to be involved in the removal from the 
circulation of opsonized particles such as bacteria and soluble immune complexes (7). 
These  processes,  however,  are  thought  to  apply  mainly  to  particles  or complexes 
containing IgG, because mononuclear phagocytes have receptors for IgG, but not, it 
appears,  for  IgM  or  IgA  (8).  Although  conflicting  claims  have  been  made,  it  is 
generally held that IgA does not fix complement and is poorly opsonic. Thus, whereas 
the protective functions of IgG and IgM antibodies in complement- and phagocytosis- 
mediated processes are well understood,  the function  of serum  IgA remains largely 
obscure. It has been suggested that the hepatobiliary transport of serum IgA serves to 
reinforce the  intestinal  supply of SIgA, which  protects the mucosal surface against 
infection and prevents the absorption of antigens from the gut lumen. 
We have considered the possibility that the hepatobiliary transport of IgA might 
also function as a  mechanism for the removal of macromolecular antigens from the 
circulation. The experiments reported here were designed to investigate this, and the 
results indicate that serum IgA antibody mediates the transport of a  foreign protein 
antigen from the circulation into the bile. 
Materials and Methods 
Anttgen.  Crystallized human  serum  albumin  (HSA)  was  substituted  with  dinitrophenyl 
(DNP)  hapten using DNP-e-aminocaproic acid  N-hydroxysuccinimide ester (Biosearch, San 
Rafael, Calif.)  (9). The degree of substitution, determined spectrophotometrically, was ~8 mol 
DNP/I tool HSA. DNP-HSA was radiolabeled with 12~I by the lactoperoxidase method (10) to 
achieve a specific activity of ~8:4 l0  s cpm/0.5 mg of protein. The labeled protein was separated 
from free label on a column of Sephadex G-25. 
* Supported by grants AI-10854 and DE-07026 from the U. S. Public Health Service, and by Procter 
and Gamble Co., lnc. 
J Abbreviations  used  in  this  paper:  DNP,  dinitrophenyl;  HSA,  human  serum  albumin;  SC,  secretory 
component; SIgA, secretory IgA. 
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Antibodies.  IgA  proteins  with  DNP-  or  levan-binding activity were  obtained  from  the 
MOPC315 and UPC61  myelomas, respectively, which were grown as ascites tumors in CB6/F1 
mice (The Jackson Laboratory, Bar Harbor, Maine). 
Monoclonal anti-DNP antibodies of IgG1 and IgM classes were prepared from hybridomas 
also grown as ascites tumors in CB6 mice. The hybridomas were prepared by the fusion of l0  s 
P3-x63-AgS.653 myeloma cells with  l0  s immune spleen cells using 41~3% polyethylene glycol 
4000 (11). The immune spleen cells were obtained from BALB/c mice immunized 1 wk earlier 
with 100 pg of DNP-keyhole limpet hemocyanin in complete Freund's adjuvant. Hybrids were 
selected in hypoxanthine, aminopterin, thymidine medium, screened for secretion of anti-DNP 
antibody by enzyme-linked immunosorbent assay, and cloned by limiting dilution. 
Immunoglobulin  concentrations  were  estimated  by  radial  immunodiffusion  using  goat 
antisera and a mouse immunoglobulin reference standard. The presence of anti-DNP antibody 
was determined by enzyme-linked immunosorbent assay (12) on microtiter plates coated with 
DNP10-HSA  (0.1  mg/ml).  Alkaline phosphatase conjugates were  prepared  from  goat  anti- 
mouse  IgG,  IgM,  or  IgA  antisera  (Bionetics Laboratory  Products,  Litton  Bionetics,  Inc., 
Kensington,  Md.).  For controls, normal  mouse  serum  and  UPC61  ascitie fluid were  used. 
Immunoglobulin class specificity of the conjugates was demonstrated  by comparing ascitic 
fluids containing monoclonal anti-DNP antibodies of IgG and  IgM classes with MOPC315 
ascitic fluid. 
Purification of IgA.  5 ml MOPC315  ascitie fluid was passed over a  15-ml column of DNP- 
Sepharose, prepared  by reacting CNBr-activated Sepharose 4B  with  ethylene diamine and 
dinitrobenzene sulfonic acid. The nonretained material was designated as depleted ascitic fluid. 
The adsorbed anti-DNP IgA was eluted with 3 M  KI, and the remaining albumin was removed 
on a  1.5-ml column of Affi-Gel Blue (Bio-Rad Laboratories, Richmond, Calif.). Immunoelec- 
trophoresis and immunodiffusion against goat antisera to mouse serum and to mouse IgA, IgG, 
and IgM showed this to be essentially pure IgA, free of other immunoglobulins but with a trace 
of albumin. Purity was also confirmed by sodium dodecyl sulfate-polyacrylamide gel electro- 
phoresis. 
Molecular Characterization oflgA.  To determine the proportions of polymeric and monomeric 
IgA, MOPC315 ascitic fluid and purified IgA were chromatographed on Sephadex G-200 (88 
×  1.5  cm)  in  0.01  M  Tris-HCl/0.14  M  NaCI,  pH  7.4.  The  distribution of IgA anti-DNP 
antibody was determined by radial immunodiffusion and enzyme-linked immunosorbent assay. 
The results indicated that MOPC315 IgA was ~75% polymeric. 
Determination of Antibody Affinities.  Anti-DNP IgG and IgM were purified from ascitic fluids 
as described above for MOPC315  lgA. Hapten dialysis (13)  was performed using 14C-DNP-E 
aminocaproic acid, which was prepared by reacting 50 #Ci (2.4 #mol) of 1  -fluoro-2,4-dinitro[U- 
~C]benzene (Amersham Corp., Arlington Heights, Ilk) with 25 #mol of e-aminocaproic acid in 
0.1  ml of 0.1 M  NaHCOa for 40 h at room temperature. Purified antibody proteins (50 pg/ml 
in  0.15%  gelatin)  were  dialyzed against  10-%10 -n M  hapten  in  0.01  M  Tris-HCl/0.14  M 
NaC1/0.01%  NaN3 for 40 h at 4°C~ Control dialyses included buffer only, and normal mouse 
IgG (N. L. Cappel Laboratories, Inc., Cochranville, Pa.) to assess nonspecific binding of hapten. 
After attainment of equilibrium, hapten concentrations inside and outside the dialysis hags 
were determined in a  Beckman  LS 8000  liquid scintillation counter  (Beckman Instruments, 
Inc., Fullerton, Calif.). KA was determined for each immunoglobulin by plotting the reciprocal 
of bound hapten concentration against the reciprocal of free hapten concentration. 
lgA Immune Complexes.  2 ml MOPC315 ascitic fluid was incubated with 0.2 ml of3eSI-DNP  - 
HSA (~0.1  mg of protein containing 1.6 X  108 cpm) for 1 h  at  room temperature, and then 
chromatographed on a column (84 ×  1.6 cm) of Sephadex G-200 in 0.15 M  NaC1.  The three 
fractions (~ 1.5 ml each) having the highest radioactivity in the void volume peak were pooled 
and used directly. 
In  Vivo Experlments.  Injection mixtures were generally prepared from 0.1  ml of t2SI-DNP- 
HSA (~50 #g of protein and 5-9 X  107 cpm) and 1 ml of ascitic fluid or serum; aliquots of 0.1 
ml were injected. With purified MOPC315 IgA, 2 ml of antibody solution (1.2 mg/ml IgA) was 
mixed with 0.1  ml of antigen, and 0.2-ml aliquots were injected. Similarly, 0.2-ml aliquots of 
isolated IgA immune complex fraction were injected. 
Locally bred BALB/c mice of both sexes, 5-8 wk of age, were starved for ~3 h  before the 970  SERUM IgA AND BILIARY TRANSPORT OF ANTIGEN 
start  of the experiment  to permit  the accumulation of bile. Eight  mice were injected  in the 
lateral tail vein with each mixture. After 1 and 3 h, four mice from each group were anesthetized 
with ether and bled from the retro-orbital  sinus. The mice were then killed and up to 10 #1 of 
bile was collected from the gall bladder with a Hamilton syringe (Hamilton Co., Inc., Whittier, 
Calif.). 
Examination of Samples.  The radioactivity of  serum and bile samples and of injection mixtures 
was measured in a Beckmap Gamma 4000 counter (Beckman Instruments,  Inc.). 
To determine  the molecular weight range of the radioactivity,  samples of injection mixtures 
and of pooled bile containing 20-100 ×  10  cpm were mixed with 0.4 ml of 1:8 diluted  normal 
mouse serum and chromatographed on a column (88 X 1.5 cm) of Sephadex G-200 eluted with 
0.01 M Tris-HCl/0.14 M NaCI, pH 7.4. The distribution  of the radioactivity  in fractions of 
~ 1.5 ml was related to the protein elution profile of mouse serum determined  by absorbance at 
280 nm. 
Staphylococcal Protein A  lmmunosorption.  Samples  were also analyzed for the  association  of 
radioactivity  with  HSA and with  immunoglobulins.  Duplicate  1-#1 aliquots  of pooled  bile 
samples and of 1:10 diluted  injection  mixtures were mixed with  10 #1 of rabbit anti-HSA or 
goat anti-mouse IgA, IgG, or IgM antisera, or normal serum. After 16 h at 4°C, 0.1 ml of a 10% 
suspension  of Staphylococcus aureus was  added  (14). After  1 h,  the  percentage  of the  total 
radioactivity  that was associated with the twice-washed staphylococci was determined. 
Statistical Analysis.  Student's t test for independent  means was applied  to logarithmically 
transformed  data. 
Results 
Requirement for Specific IgA Antibody b~ the Hepatobiliary  Transport of Antigen.  The levels 
of radioactivity in the serum and bile of mice injected with 125I-DNP-HSA and various 
antibody-containing fluids  are  shown  in  Table  I.  At  1 and  3  h,  the  bile  of mice 
receiving MOPC315 and lz~I-DNP-HSA contained high levels of radioactivity, which 
at 3 h  exceeded the radioactivity present  in the serum.  In contrast, the bile of mice 
injected with normal serum and a~I-DNP-HSA contained low levels of radioactivity. 
The difference in bile radioactivity between the two groups was highly significant (P 
<  0.001) at both sampling times. The levels  of radioactivity in the bile of mice given 
ascitic fluid containing anti-levan IgA (UPC61)  were similar  to those of the serum 
controls. The injection of unhaptenated a2nI-HSA with MOPC315 aseitic fluid resulted 
in the recovery of only low levels  of radioactivity in the bile. These results indicated 
that the transport of antigen into bile required specific antibody. 
When  MOPC315  ascitic  fluid  depleted  of anti-DNP IgA was  injected  with  lusI- 
DNP-HSA, the recovery of radioactivity in bile remained low and was significantly 
different from that obtained with the original MOPC315 aseitic fluid (P <  0.001)  at 
both sampling times. However, with the use of purified MOPC315 IgA, large amounts 
of radioactivity were recovered in the bile. Thus, it was concluded that the transport 
of antigen into bile was mediated by IgA antibody. 
To determine whether hepatobiliary transport of antigen is a  unique property of 
IgA, 125I-DNP-HSA was injected together with the ascitic fluids of anti-DNP hybri- 
domas  containing  IgG  or  IgM  antibody.  With  the  IgM  antibody,  there  was  no 
significant  transport  of radioactivity into  the  bile,  in  comparison with  the  normal 
serum controls. However, with IgG antibody, there was a  significant level  of radio- 
activity in the bile (P <  0.001, compared with IgM or normal serum control), but this 
was substantially  less than  the  bile  radioactivity obtained  when  IgA antibody was 
used. In comparison with IgA or IgM antibody, the serum levels of radioactivity were 
lower in the mice given IgG, although similar amounts of radioactivity were injected MICHAEL W.  RUSSELL, THOMAS A.  BROWN,  AND JIRI  MESTECKY 
TABLE  I 
IgA Antibody-dependent Specific Transport of Antzgen into Bile 
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128I.DNP-HSA 
Antibody fluid injected  injected  Time 
Radioactivity recovered 
(mean ±  SD) 
Serum  Bile 
cpm  h  cpm/~l 
MOPC315 ascitic fluid*  6.9 ×  105  1  2,723 + 491  2,247 -  590 
3  1,886 ±  110  3,840 +  739 
Normal serum  7.5 ×  106  1  3,485 +  474  286 +  33 
3  2,852 +  171  227± 31 
UPC61 ascitic fluid  7.6 X 106  1  3,792 ± 481  324 ±  51 
3  2,992 ±  393  263 ±  21:t: 
Depleted MOPC315 ascitic fluid§  6.2 ×  106  1  3,640 ±  486  293 ±  30 
3  2,715 ±  195  285 ±  71 
Purified MOPC315 IgAII  5.3 ×  108  1  2,465 ±  120  2,939 ±  534 
3  1,761 ±  82  1,465 ±  182 
Anti-DNP IgM ascitic fluid¶  8.4 ×  10  a  1  4,800 ±  163  244 -  20 
3  4,104 ±  579  256± 27 
Anti-DNP IgG ascitic fluid**  8.9 ×  108  1  1,912 ±  187  786 ±  204 
3  1,482 ±  182  605 _+ 26 
MOPC315 ascitic fluid  12SI-HSA  1  18,317 +  749  886 ±  210 
24 ×  108  3  14,239 ±  1,910  658 ±  139 
*Contained 27 mg/ml lgA. Anti-DNP titer (IgA) =  3 X 106. KA =  1.2 ×  10 7 M -1, 
:~ Three animals. 
§ Contained 0.13 mg/ml IgA. Anti-DNP titer (IgA) <  1 ×  10  2, 
II Contained  1.2 mg/ml lgA. Anti-DNP titer (IgA) =  2.4 ×  10  5. 
¶ Contained 4.0 mg/ml IgM. Anti-DNP titer (IgM)  =  1.3 ×  10  6. KA =  3.0 ×  10  6 M -~. 
** Contained 14.5 mg/ml IgG. Anti-DNP titer (IgG) =  6.4 ×  10  5. K^ =  1.6 ×  10  7 M -1. 
into  each  group  of mice.  It  was  conjectured  that  this  was  due  to  the  clearance  of 
immune  complexes containing  IgG and  125I-DNP-HSA by  the  mononuclear  phago- 
cytic  system,  which  includes  the  Kupffer  cells of the  liver.  As  a  result,  radioactive 
breakdown  fragments  might  be  released  into  the  bile.  On  the  other  hand,  IgA- 
mediated  transport  of radiolabeled  antigen  into  the  bile  through  the  hepatocytes 
should  not necessarily involve breakdown  of the antigen.  Bile samples were therefore 
analyzed  to determine  the molecular weight range of the radioactivity. 
Analysis  of Radiolabeled Antigen  Transported to  Bile.  When  the  bile of mice  injected 
with  anti-DNP  IgG  and  12SI-DNP-HSA  was  chromatographed  on  Sephadex  G200, 
the radioactivity was confined to the low molecular weight  fractions  (Fig.  1 A). This 
was  in  sharp  contrast  to  the elution  profiles of bile samples  from  mice injected with 
immune  complexes of MOPC315  IgA and 12SI-DNP-HSA (see below; Fig.  1 C). In the 
latter,  -70%  of  the  recovered  radioactivity  was  present  in  the  void  volume  and 
albumin  fractions together. These results therefore indicated that  IgA antibody could 
mediate  the hepatobiliary  transport  of antigen  that  was  largely  intact,  whereas  IgG 
antibody  brought  about  the  appearance  in  bile of only  low  molecular weight  frag- 
ments. 
To  confirm  these  findings,  attempts  were  made  to  determine  the  binding  of 
radioactivity  in  bile by  antisera  to  HSA  and  to  immunoglobulin,  using  a  staphylo- 
coccal immunosorption  assay.  For comparison,  injection mixtures were also analyzed. 
In  the  bile  taken  from  mice  after  injection with  MOPC315  ascitic  fluid  and  12sI- 972  SERUM  IgA  AND  BILIARY  TRANSPORT  OF  ANTIGEN 
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Flo.  I.  Sephadex  G-200  chromatography  of: A, bile ! h after injection oflsG anti-DNP hybridoma 
ascitic fluid and 12SI-DNP-HSA; B, separated immune complex fraction prepared from MOPC3 15 
ascitic  fluid  and  125I-DNP-HSA; C,  bile  1 h  after  injection  of separated immune complex of 
MOPC3 15 and t25I-DNP-HSA. 
DNP-HSA, ~60% of the radioactivity was bound by anti-HSA serum, and 50% was 
bound by anti-IgA serum. However, in the controls, 28% of the bile radioactivity was 
bound to staphylococci in the absence of specific antibody. Similar analysis of the 
injection mixture of MOPC315 ascitic fluid and I~bI-DNP-HSA showed that 78% of 
the radioactivity was bound by anti-HSA, 50% was bound by antioIgA, and 7% was 
bound directly by the staphylococci. It therefore appeared  that components of the 
bile itself influenced the direct binding of either the labeled antigen or the putative 
IgA immune complexes to the staphylococci. In the bile of mice injected with anti- 
DNP  IgG  and  I~I-DNP-HSA,  the  radioactivity  was  not  appreciably  bound  by 
antisera  to  HSA  (4.3%) or  IgG  (3.5%),  or directly by staphylococci  (2.1%).  These 
results were compatible with those obtained by the chromatographic analysis of bile 
samples, and it was therefore concluded that at least part of the antigen transported 
into bile by IgA antibody remained intact and also bound to IgA. In contrast, the 
much lower amount of radioactivity present in the bile of mice injected with IgG was 
associated with fragments of degraded antigen. 
Biliary Transport of Preformed Complexes of MOPC315 IgA and 1zSI-DNP-HSA.  When 
separated, preformed immune complexes of MOPC315 IgA and 125I-DNpoHSA were 
injected into mice, high levels of radioactivity, relative to serum, were observed in the 
bile (Table II). In the injected complex, 93% of the radioactivity was bound by anti- 
HSA and 63% was bound by anti-IgA antiserum. Sephadex G-200 chromatography 
showed that most of the radioactivity was in the void volume, but  that some had 
dissociated and was present in the albumin fraction (Fig.  1 B). The Sephadex G-200 
elution profile of the bile showed radioactivity in the void volume, albumin, and low 
molecular weight fractions (Fig.  1 C). In the control mice, which received a  similar 
amount of I~I-DNP-HSA  in  10%  normal serum,  bile  radioactivity remained  low. 
Thus, it was concluded that immune complexes of IgA and antigen were efficiently 
transported into bile. MICHAEL W.  RUSSELL, THOMAS A. BROWN, AND JIRI  MESTECKY 
TABLE II 
Transport of Preformed  IgA Immune Complexes into Bile 
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Percentage of injected radioactivity 
Material injected  bound by antiserum to  Time 
Radioactivity 
(mean ±  SD) 
HSA  IgA  IgG  IgM  Control  Serum  Bile 
h  cpm/#l 
Immune complex  93  63  12  7.1  5.0  1  329 ±  5.3  1,103 ±  233 
(1.1  ×  10  ~ cpm)  3  208 ±  50  650 ±  200 
Antigen  control  84  0.3  0.8  0.5  0.1  1  797 +  108  47 ±  5.0 
(1.5 X  106 cpm)  3  718 ±  152  61 ±  15 
Although much of the transported antigen remained intact and partly complexed 
to IgA antibody, it was apparent that there was also a certain amount of breakdown. 
This breakdown may have occurred in transit through the liver, or in the bile. To test 
the latter possibility, preformed immune complexes of 125I-DNP-HSA and MOPC315 
IgA were incubated with normal bile in vitro for 1 h  at 37°C.  Subsequent chroma- 
tography on Sephadex G-200 did not reveal any change in the elution profile of the 
radioactivity in the complex. Thus, it appeared that breakdown of antigen may have 
occurred within the liver. 
Discussion 
The results presented here demonstrate that  specific IgA antibody mediated the 
transport of a haptenated protein from the circulation to the bile. At least part of the 
antigen was present in the bile in intact form and was bound to IgA. This finding 
implies that  degradation of the antigen was not a  prerequisite of its transport into 
bile. 
In contrast, transfer of the haptenated protein was not mediated by IgM antibody, 
and IgG brought about the appearance in bile of only small amounts of low molecular 
weight fragments. It seems most likely that this was due to phagocytosis and digestion 
of IgG-antigen complexes by the Kupffer cells, which possess receptors for IgG (15). 
The failure to observe biliary transport of antigen by IgM or IgG antibody was not 
attributable  to  lack  of affinity for DNP.  Both  IgM  and  IgG  antibodies  had  high 
association constants  that  were comparable with that  of MOPC315  IgA  (Table I). 
Furthermore, we have found that another IgA protein, MOPC460, which binds DNP 
with lower affinity (KA =  3 X  105 M -1) (16) than the anti-DNP IgG and IgM used in 
these studies, will also mediate the transport of 12~I-DNP-HSA to bile (M. W. Russell, 
T. A. Brown, and J. Mestecky, unpublished observations). 
In  all  of the  present  experiments, anti-DNP  antibody was  used  in  considerable 
excess over the amount of antigen. Lack of hepatobiliary transport by IgG and IgM 
antibody cannot  therefore be attributed  to insufficient antibody.  It  remains  to be 
investigated  whether  the  IgA:antigen  ratio  and  the  size  and  composition  of IgA- 
antigen complexes will affect the efficiency of the transport. 
The  mechanism  responsible  for  the  appearance  of  IgA  in  bile  has  not  been 
conclusively established. In rats, the transport of IgA from the circulation to the bile 
is mediated by SC, which functions as a receptor for IgA on the hepatocyte membrane, 
and  is  selective  for  polymeric  forms  (5,  6).  The  MOPC315  protein  used  in  our 974  SERUM  IgA  AND  BILIARY TRANSPORT OF  ANTIGEN 
experiments  was  75%  polymeric.  It  is  likely  that  the  transport  of IgA  immune 
complexes through the hepatocytes is analogous to the transport of free IgA. Although 
human hepatocytes selectively bind polymeric IgA, SC has not been detected on their 
surfaces (17,  18). It remains to be investigated whether other secretory glands, which 
transport polymeric IgA across the epithelium to generate SIgA, might also be capable 
of transporting antigen complexed with IgA. 
There  are  other  mechanisms  of uptake  of immune  complexes  by  the  liver.  In 
addition to the clearance of IgG immune complexes by Kupffer cells (19), mannose 
receptors on nonparenchymal cells have been implicated in the binding of immune 
complexes that contained IgM  (20).  However, these mechanisms do not explain our 
observations that hepatobiliary transport of immune complexes was selective for IgA 
rather than for IgG or IgM.  In this connection, HSA, which is not a  glycoprotein, 
would not bind directly to carbohydrate receptors. 
The results presented here suggest a  beneficial role for serum IgA, in contrast to 
potentially deleterious effects such as the inhibition of complement-mediated bacte- 
riolysis, neutrophil chemotaxis, and phagocytosis (21-23). The rapid clearance of IgA 
immune complexes from the circulation has recently been described (24), but the site 
or mechanism of removal was  not  investigated. This observation is consistent with 
our results,  which  demonstrate the specific IgA-mediated transport of antigen  into 
bile. 
In the intestine, antigens that penetrate the mucosal barrier and become absorbed 
would  encounter an  abundant  supply of IgA produced by the submucosal  plasma 
cells (25). Much of this IgA is secreted through the epithelium as SIgA, and  might 
conceivably re-export antigens immediately in the form of immune complexes. Some 
of this IgA, however, is carried to the liver and could thereby mediate the excretion 
of absorbed antigens into the bile. This process could help explain the apparent role 
of the liver in limiting the systemic immune response to antigens absorbed in the gut 
(26).  Antigens  absorbed  through  other  mucosal  surfaces,  e.g.,  the  lungs  and  the 
bronchial  tree, or generated by infectious agents,  might  also  be eliminated  by the 
liver in this way. 
Although the role of SIgA in protecting mucosal surfaces is generally accepted, the 
function  of serum  IgA  has  been  inadequately  investigated.  We  propose  that  an 
important and hitherto undisclosed function of serum IgA is to mediate the removal 
of antigens  from the circulation to the bile by a  mechanism  that  may be found to 
circumvent  the  inflammatory consequences of the  activation  of complement  and 
phagocytosis. 
Summary 
The  IgA-mediated  hepatobiliary  excretion  of antigen  from  the  circulation  was 
studied using a  radiolabeled haptenated protein (dinitrophenyl-human serum albu- 
min)  injected  intravenously  in  mice  together with  monoclonal  anti-dinitrophenyl 
antibodies of different immunoglobulin classes.  Antibodies were obtained from ascitic 
fluids of mice bearing the MOPC315  myeloma (IgA), or immune spleen cell hybri- 
domas (IgG and IgM). IgA antibody brought about the transport of large amounts of 
antigen from the circulation to the bile during 1-3 h. Analysis of bile by gel filtration 
showed that a large part of the transported antigen remained intact and complexed 
with  IgA.  Neither IgA of different specificity nor anti-dinitrophenyl IgM mediated MICHAEL W.  RUSSELL,  THOMAS A.  BROWN,  AND JIRI MESTECKY  975 
biliary transport of antigen. With anti-dinitrophenyl  IgG, only small amounts of low 
molecular  weight  fragments  of labeled  antigen  were  found  in  the  bile.  Preformed 
immune complexes of radiolabeled antigen and IgA antibody were rapidly transported 
from the circulation to the bile, resulting in threefold-higher levels of radioactivity in 
bile  than  in  serum.  It  is  proposed  that  an  important  function  of serum  IgA is  to 
mediate the hepatobiliary excretion of corresponding circulating antigens. 
We thank Dr. John F. Kearney for valuable assistance with the development of hybridomas, 
and Rose Kulhavy for skilled  technical assistance. 
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